Huimin Zhou
Jiangnan University(CN)Tongji University(CN)Tianjin University of Technology(CN)Kunming University(CN)University of Shanghai for Science and Technology(CN)Sun Yat-sen University(CN)Dalian Medical University(CN)Wuhan University(CN)Soochow University(CN)Jiangsu Academy of Agricultural Sciences(CN)Wuxi Fourth People's Hospital(CN)Zhongnan Hospital of Wuhan University(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)Jiangxi Mental Health Center(CN)First Affiliated Hospital of Hebei Medical University(CN)Xijing Hospital(CN)Tongji Hospital(CN)Huazhong University of Science and Technology(CN)Beihang University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Glycosylation and Glycoproteins Research, RNA modifications and cancer, MicroRNA in disease regulation, Blood Pressure and Hypertension Studies, Diabetes Treatment and Management
Most-Cited Works
- → Dislocations that Decrease Size Mismatch within the Lattice Leading to Ultrawide Band Gap, Large Second‐Order Susceptibility, and High Nonlinear Optical Performance of AgGaS2(2019)174 cited
- → MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway(2017)156 cited
- → Early prediction of acute xerostomia during radiation therapy for nasopharyngeal cancer based on delta radiomics from CT images(2019)88 cited
- → Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial(2013)83 cited
- → HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway(2019)81 cited
- → miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway